## Treatment-Resistant OCD: Definition and Approach **Key Point:** Treatment-resistant OCD is defined as inadequate response (<25% reduction in Y-BOCS) after 8–12 weeks of an adequate dose of a first-line SSRI. This patient meets criteria for treatment resistance (only 10–15% improvement on sertraline 200 mg for 12 weeks). **High-Yield:** The most effective next step in treatment-resistant OCD is to combine pharmacotherapy with evidence-based psychotherapy (CBT/ERP), rather than medication adjustment alone. CBT/ERP has Level 1 evidence for OCD and should be offered to all patients, especially those with inadequate pharmacological response. ## Management Algorithm for Treatment-Resistant OCD ```mermaid flowchart TD A[OCD on SSRI 8-12 weeks]:::outcome --> B{Response ≥25% Y-BOCS reduction?}:::decision B -->|Yes| C[Continue SSRI, optimize dose]:::action B -->|No| D[Treatment-resistant OCD]:::urgent D --> E{Has patient received CBT/ERP?}:::decision E -->|No| F[Initiate CBT/ERP + continue SSRI]:::action E -->|Yes| G{Adequate trial of ERP?}:::decision G -->|No| H[Optimize ERP intensity/frequency]:::action G -->|Yes| I[Switch/augment pharmacotherapy]:::action I --> J{Options}:::decision J -->|Try clomipramine| K[Clomipramine 100-250 mg]:::action J -->|Augment SSRI| L[Add antipsychotic or increase dose]:::action ``` ## Why CBT/ERP + Pharmacotherapy Is Correct 1. **Evidence hierarchy:** CBT/ERP is Level 1 evidence for OCD and has demonstrated superiority to medication alone in multiple RCTs and meta-analyses. 2. **Patient has not received psychotherapy:** This is the first opportunity to offer the gold-standard psychological intervention; it should be attempted before further medication changes. 3. **Combination approach:** SSRI + CBT/ERP produces superior outcomes compared to either modality alone, with response rates of 60–80% in treatment-resistant cases. 4. **Y-BOCS score indicates moderate-to-severe disease:** A score of 32 warrants intensive treatment, and CBT/ERP is the most intensive evidence-based psychological intervention. **Clinical Pearl:** The patient's lack of prior exposure therapy is a critical gap. Many patients initially labeled "treatment-resistant" respond well once adequate ERP is introduced, even on the same medication dose. ## Comparison of Next-Step Options | Option | Rationale | Evidence | Timing | |--------|-----------|----------|--------| | **Add CBT/ERP** | First-line for treatment-resistant OCD; patient has not yet received it | Level 1 (RCTs, meta-analyses) | Initiate immediately alongside SSRI | | Switch to clomipramine | Second-line SSRI alternative; reasonable if CBT/ERP unavailable or refused | Level 1 but second-line | Consider after CBT/ERP trial or if psychotherapy unavailable | | Increase sertraline to 300 mg | Exceeds FDA-approved maximum (200 mg); limited evidence for higher doses | Level 3 (expert opinion) | Not recommended; dose already adequate | | Add risperidone | Augmentation strategy for SSRI non-response; but should follow CBT/ERP trial first | Level 2 (open trials) | Reserved for after CBT/ERP optimization | **Mnemonic:** **CBT First, Then Meds Adjust** — In treatment-resistant OCD, always optimize psychotherapy before escalating pharmacotherapy. ## Implementation of CBT/ERP **High-Yield:** Effective ERP for contamination OCD involves: - **Exposure:** Deliberate contact with feared contaminants (e.g., touching doorknobs, soil) without avoidance. - **Response Prevention:** Resisting the urge to wash, clean, or ritualize after exposure. - **Frequency:** Typically 1–2 sessions per week for 12–16 weeks; may require intensive formats (e.g., 5 days per week) for severe cases. - **Therapist:** Should be trained in OCD-specific CBT/ERP (not general CBT). [cite:Harrison 21e Ch 389; American Psychiatric Association Practice Guideline for OCD] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.